DRS

NIMML Institute’s TITAN-X A.I.-Powered Precision Medicine Platform Validated through AbbVie’s Acquisition of Landos Biopharma and Lead Clinical Candidate NX-13

Retrieved on: 
Monday, March 25, 2024
Health, Health Technology, Clinical Trials, Research, Science, Pharmaceutical, Biotechnology, AbbVie, Ulcerative colitis, Growth, I&I, Cell, ACG, Patient, ABBV, UC, Journal, Biomarker, NIMML, Acquisition, LANCL2, IPO, SLE, Personalized medicine, Volunteering, A.I, IBD, Medicine, Rheumatoid arthritis, Epithelium, DRS, Invention, Therapy, NLRX1, Work, Pharmaceutical industry

and computational modeling capabilities were instrumental for the characterization of NLRX1 as a therapeutic target for autoimmune diseases and the development of NX-13.

Key Points: 
  • and computational modeling capabilities were instrumental for the characterization of NLRX1 as a therapeutic target for autoimmune diseases and the development of NX-13.
  • “Importantly, AbbVie is one of the world’s largest biopharma companies with an incredibly successful I&I franchise that it has built over the last two decades.
  • In addition to Landos Biopharma, Dr. Bassaganya-Riera founded NImmune Biopharma (“NImmune”) with the purpose to advance the clinical development of the LANCL2 portfolio of immunoregulatory precision medicines.
  • Both omilancor and NIM-1324 are guided by precision biomarkers discovered and developed by NIMML’s TITAN-X A.I.-powered Precision Medicine platform.

Verastem Oncology Announces Multiple Oral Presentations at SGO 2024 Annual Meeting on Women’s Cancer that Highlight Advances in Low-Grade Serous Ovarian Cancer Research and Reinforce Commitment to Addressing Urgent Unmet Needs

Retrieved on: 
Monday, March 11, 2024
Biotechnology, General Health, Health, Pharmaceutical, Oncology, FAK, Patient, Research, RAMP, Cancer, SGO, Society, Woman, Clinical trial, Verastem Oncology, DRS, MEK, Gynecologic Oncology (journal), Consultant, Annual general meeting, Pharmaceutical industry

Verastem will have an exhibition booth (#420) at the meeting to provide an overview of its ongoing cancer research.

Key Points: 
  • Verastem will have an exhibition booth (#420) at the meeting to provide an overview of its ongoing cancer research.
  • “In addition, the plenary oral presentation highlighting preclinical efficacy of avutometinib in combination with a FAK inhibitor reinforces the potential of this combination in low-grade serous ovarian cancer regardless of KRAS status.
  • Banerjee and Grisham are paid consultants for Verastem Oncology.
  • The multinational survey is supported by Verastem Oncology.

Steps2Walk Announces the Impact of Q1 Surgical Mission and Orthopedic Training Programs

Retrieved on: 
Thursday, April 4, 2024
Walking, Partnership, Education, Patient, Foot, Child, Cadaver, Telehealth, Surgeon, Deformity, DRS, Nursing

DENVER, April 4, 2024 /PRNewswire-PRWeb/ -- Steps2Walk, a global humanitarian nonprofit organization providing surgical missions and surgeon training in under-served regions around the world, today announced the patient and educational impact of its first round of programs for 2024. In February and March, the organization conducted programs in Sri Lanka, Pakistan, and for the first time, Tanzania, treating 50 patients and providing surgical training and education to 120 local surgeons.

Key Points: 
  • Founded in 2000 by world-renowned orthopedic surgeon Dr. Mark Myerson , the organization addresses the surgical needs of those with severe foot and ankle deformities in regions where there is limited orthopedic care.
  • Each mission is organized in partnership with the Steps2Walk team, their international network of volunteer surgeons and the hosting medical institutions.
  • Steps2Walk has four upcoming programs scheduled for Q2:
    For more information on how to become a volunteer faculty member or trainee participant in one of the Steps2Walk Programs, visit https://steps2walk.org/faculty/ .
  • Steps2Walk also accepts donations , which can give the gift of walking to those most in need and help fund critical training and education for regional orthopedic surgeons.

RSNA: Early Coronary Disease, Impaired Heart Function Found in Asymptomatic People with HIV

Retrieved on: 
Thursday, April 4, 2024
Biomedicine, Cardiovascular disease, MRI, Coronary artery disease, HIV, Didanosine, Viral load, Education, Patient, Facial muscles, Research, Kidney, University, Death, Physical examination, NIH, Society, Life expectancy, Risk, Moyamoya disease, OAK, World Health Organization, RSNA, DRS, Heart, Radiation, Bangladesh Technical Education Board, Digestive, Synthetic control method, Health, Person, Pharmaceutical industry

OAK BROOK, Ill., April 4, 2024 /PRNewswire-PRWeb/ -- A new study found increased coronary vessel wall thickness that was significantly associated with impaired diastolic function in asymptomatic, middle-aged individuals living with HIV. The study was published today in Radiology: Cardiothoracic Imaging, a journal of the Radiological Society of North America (RSNA).

Key Points: 
  • A new study found increased coronary vessel wall thickness that was significantly associated with impaired diastolic function in asymptomatic, middle-aged individuals living with HIV.
  • The ability to detect early coronary artery disease in persons living with HIV and potentially prevent detrimental effects on the heart muscle is important.
  • This research shows the impact of HIV on developing subtle subclinical coronary artery disease and its effects on heart function.
  • "This research shows the impact of HIV on developing subtle subclinical coronary artery disease and its effects on heart function."

Gateway Aesthetic Announces Relocation to a New, Modern Facility

Retrieved on: 
Tuesday, April 2, 2024
Laser, Patient, Multimedia, Skin, Acne, McClean, Birthmark, Blepharoplasty, Heart, Physician, Society, Instrument, DRS, Scalp, Dentistry

SALT LAKE CITY, April 2, 2024 /PRNewswire-PRWeb/ -- Gateway Aesthetic, an established cosmetic and surgical dermatology clinic, is pleased to announce its relocation to a new, state-of-the-art facility at 650 South Main Street. The new location, in the heart of Salt Lake City's thriving Central Business District, will be at the vanguard of elite aesthetic practices. Thoughtfully envisioned to provide an exceptional patient experience from consult through treatment, this new, modern location is equipped with the most effective lasers and energy-based technologies to deliver meaningfully transformative results to patients.

Key Points: 
  • Gateway Aesthetic, an established cosmetic and surgical dermatology clinic, is pleased to announce its relocation to a new, state-of-the-art facility at 650 South Main Street.
  • SALT LAKE CITY, April 2, 2024 /PRNewswire-PRWeb/ -- Gateway Aesthetic, an established cosmetic and surgical dermatology clinic, is pleased to announce its relocation to a new, state-of-the-art facility at 650 South Main Street.
  • The physicians at Gateway Aesthetic are known for performing a number of unique and highly sought-after advanced specialty treatments.
  • The physicians at Gateway Aesthetic are known for performing a number of unique and highly sought-after advanced specialty treatments.

Montgomery County Domestic Relations Announces Partnership With GreenCourt

Retrieved on: 
Monday, April 1, 2024
Partnership, Automation, Workflow, DRS, Parent, Green, Food delivery

CARROLLTON, Ga., April 1, 2024 /PRNewswire-PRWeb/ -- The Montgomery County Domestic Relations Section (DRS) announces its partnership with GreenCourt Legal Technologies, LLC (GreenCourt) to enhance service to families by modernizing the electronic filing and acceptance of documents.

Key Points: 
  • The Montgomery County Domestic Relations Section announces partnership with GreenCourt to enhance service to families.
  • CARROLLTON, Ga., April 1, 2024 /PRNewswire-PRWeb/ -- The Montgomery County Domestic Relations Section (DRS) announces its partnership with GreenCourt Legal Technologies, LLC (GreenCourt) to enhance service to families by modernizing the electronic filing and acceptance of documents.
  • Child support parents and attorneys file hundreds of documents weekly with the Montgomery County DRS.
  • "At DRS, we strive to provide superior service to the residents of Montgomery County in every facet of our operations," said Jaime B. Trupp, Director of Montgomery County Domestic Relations.

Mechanism Found to Determine which Memories Last

Retrieved on: 
Thursday, March 28, 2024
Reward, Brain, Cell, NYU Langone Health, Memory, Hippocampus, Physiology, Sleep, Research, Science, Mammal, NYU, Electrode, Doctor of Philosophy, National Institutes of Health, MD, Human, Neuron, DRS, Multimedia, Swings, Animal, Medical imaging

Now, a new study proposes a mechanism that determines which memories are tagged as important enough to linger in the brain until sleep makes them permanent.

Key Points: 
  • Now, a new study proposes a mechanism that determines which memories are tagged as important enough to linger in the brain until sleep makes them permanent.
  • Events followed by very few or no sharp wave-ripples failed to form lasting memories.
  • The current study found that sharp wave-ripples represent the natural tagging mechanism during such pauses after waking experiences, with the tagged neuronal patterns reactivated during post-task sleep.
  • For memories that are remembered, those same cells fire at high speed, as we sleep, "playing back the recorded event thousands times per night."

Data-Science-Powered Research by Seattle Children's and Microsoft Shows Promise of Predicting SIDS and Other Causes of Sudden Death

Retrieved on: 
Thursday, March 28, 2024
Gene, Sudden death, Herbal cigarette, SIDS, Learning, Medical genetics, Child, Infant, Electronic cigarette, Oxygen, Rutgers University, Research institute, Microsoft, Partnership, Risk, International, Pediatrics, Death, Fatality, Seattle Children's, Preterm birth, Database, American Journal, Research, AI, University, Pregnancy, DRS, Cardiac arrest, Hypoxia, Genetic testing, Developing Story, Mortality, SUID, Doctor of Philosophy, Life, Smoking, Summit, Pacific Northwest, Medical device

The event was sponsored by The Center for Integrative Brain Research at Seattle Children's and Microsoft AI for Good Lab.

Key Points: 
  • The event was sponsored by The Center for Integrative Brain Research at Seattle Children's and Microsoft AI for Good Lab.
  • Among the many topics attendees discussed was groundbreaking new research that suggests genetic testing at birth may hold the promise of detecting SIDS risk — and potentially other causes of sudden death later in life.
  • The Aaron Matthew SIDS Research Foundation funds the database, which is maintained and managed at Seattle Children's Research Institute.
  • "Scientific research sometimes leads to surprises," said Jan-Marino Ramirez , PhD, Director of the Center for Integrative Brain Research at Seattle Children's.

ICIS Launches State of Play 2024 Study Providing Comprehensive Insights into the PET Market in Europe

Retrieved on: 
Wednesday, March 27, 2024
Plastic recycling, Waste management, Recycling, PET, RPET, Design, DRS, ICIS, Collection, DFR

Key highlights of the State of Play 2024 study include:

Key Points: 
  • Key highlights of the State of Play 2024 study include:
    PET collection rate in 2022 increased to 60%, from the total of 5 million tonnes of PET resin utilised in the region.
  • "We are excited to present the State of Play 2024 study, a comprehensive analysis of the European PET market.
  • ICIS conducted the study in conjunction with partners, including Plastics Recyclers Europe, Natural Mineral Waters Europe, Petcore Europe, and UNESDA Soft Drinks Europe.
  • For more information on the State of Play 2024 study and to access the full report, visit https://www.plasticsrecyclers.eu/wp-content/uploads/2024/03/PET-Market-i...

ICIS Launches State of Play 2024 Study Providing Comprehensive Insights into the PET Market in Europe

Retrieved on: 
Wednesday, March 27, 2024
Plastic recycling, Waste management, Recycling, PET, RPET, Design, DRS, ICIS, Collection, DFR

Key highlights of the State of Play 2024 study include:

Key Points: 
  • Key highlights of the State of Play 2024 study include:
    PET collection rate in 2022 increased to 60%, from the total of 5 million tonnes of PET resin utilised in the region.
  • "We are excited to present the State of Play 2024 study, a comprehensive analysis of the European PET market.
  • ICIS conducted the study in conjunction with partners, including Plastics Recyclers Europe, Natural Mineral Waters Europe, Petcore Europe, and UNESDA Soft Drinks Europe.
  • For more information on the State of Play 2024 study and to access the full report, visit https://www.plasticsrecyclers.eu/wp-content/uploads/2024/03/PET-Market-i...